BridgeMD
New treatment option for Cancer Survivors
Official title Multidisciplinary Rehabilitation of Children and Adolescents After Acute Cancer Treatment
ClinicalTrials.gov ID: NCT05154305
What this study is testing
- What it's testing
- Recent numbers display a 85% survival-rate in children after a very harmful disease such as cancer. However, the survivors still experience mild to severe side effects of the primary disease or treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 21
You may be able to join if
- between 6 months and 8 years post acute cancer treatment
- off medical treatment
- all possible cancer diagnosis, except for brain tumors and sarcomas
You likely can't join if
- not able to participate for 3 consecutive weeks
- not able to perform a maximal cardiopulmonary exercise test
- unwilling to cooperate
- relapse
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 21 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.